Barclays
BCYC icon

Barclays’s Bicycle Therapeutics BCYC Stock Holding History

Barclays’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15.6K Buy
4,244
+1,095
+35% +$4.43K ﹤0.01% 4777
2026
Q2 		$13.4K Buy
3,149
+792
+34% +$3.63K ﹤0.01% 4661
2026
Q1 		$10.9K Buy
2,357
+1,795
+319% +$10.3K ﹤0.01% 4687
2025
Q4 		$3.98K Sell
562
-1,710
-75% -$12.6K ﹤0.01% 5001
2025
Q3 		$17.6K Sell
2,272
-1,204
-35% -$9.09K ﹤0.01% 4959
2025
Q2 		$24.2K Buy
3,476
+168
+5% +$1.34K ﹤0.01% 4824
2025
Q1 		$28.1K Buy
3,308
+696
+27% +$8.2K ﹤0.01% 4737
2024
Q4 		$36.6K Buy
2,612
+2,345
+878% +$50.3K ﹤0.01% 4821
2024
Q3 		$6.04K Buy
267
+183
+218% +$4.22K ﹤0.01% 5016
2024
Q2 		$1.7K Hold
84
– – ﹤0.01% 4657
2024
Q1 		$2.09K Sell
84
-14,948
-99% -$318K ﹤0.01% 4913
2023
Q4 		$272K Buy
15,032
+14,864
+8,848% +$246K ﹤0.01% 4272
2023
Q3 		$3.38K Buy
168
+84
+100% +$1.92K ﹤0.01% 4422
2023
Q2 		$2.14K Hold
84
– – ﹤0.01% 4319
2023
Q1 		$1.79K Buy
+84
New +$2.11K ﹤0.01% 4898
2022
Q2 		– Sell
-2,129
Closed -$93K – 5020
2022
Q1 		$93K Sell
2,129
-1,471
-41% -$68.7K ﹤0.01% 3816
2021
Q4 		$219K Sell
3,600
-2,522
-41% -$139K ﹤0.01% 3530
2021
Q3 		$255K Buy
6,122
+1,522
+33% +$53.2K ﹤0.01% 3495
2021
Q2 		$140K Sell
4,600
-15,900
-78% -$480K ﹤0.01% 3707
2021
Q1 		$612K Buy
+20,500
New +$529K ﹤0.01% 3072

Other funds holding BCYC

GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
Peapod Lane Capital
Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Woodstock Corp
Woodstock Corp Boston, Massachusetts $1.24B AUM 22.02% 1-Year Est. Return
RS
R Squared Central, Hong Kong $188M AUM 18.2% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.71B AUM 23.29% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $29.2B AUM 30.02% 1-Year Est. Return

Barclays's BCYC Position: Q3 2026 in Review

Barclays increased its Bicycle Therapeutics (BCYC) stake by 35% in Q3 2026, buying an estimated $4.43K and bringing the position to 4,244 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4777.

Barclays first reported a position in BCYC in Q1 2021 and has held it in 20 quarters since. The position peaked at $612K in Q1 2021. 25 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.

  • Barclays held 4,244 shares of Bicycle Therapeutics worth $15.6K as of Q3 2026.
  • Barclays bought 1,095 Bicycle Therapeutics shares in Q3 2026, an estimated $4.43K.
  • Bicycle Therapeutics made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4777 holding.
  • Barclays first reported a position in Bicycle Therapeutics in Q1 2021 and has held it in 20 quarters since.
  • Barclays's Bicycle Therapeutics position peaked at $612K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.